论文部分内容阅读
1981年12月--1990年10月我们收治了喘憋型肺炎104例,随机分为两组,酚妥拉明治疗组63例,对照组41例,两组病程分布及临床表现情况基本一致。结果显示,酚妥拉明治疗喘憋型肺炎较之对照组疗效显著、安全、无明显副作用。初步探讨酚妥拉明在治疗喘憋型肺炎中的作用机理可能为改善心功能,改善肺微循环,解除支气管痉挛等。认为只要掌握适应症,注意补充血容量,酚妥拉明可作为喘憋型肺炎的常规辅助用药。
December 1981 - October 1990, we admitted 104 cases of wheezing pneumonia, were randomly divided into two groups, 63 cases of phentolamine treatment group, 41 cases of control group, the course of disease distribution and clinical performance of the two groups were basically the same . The results showed that phentolamine treatment of asthmatic pneumonia compared with the control group significant effect, safe, no significant side effects. Preliminary study of phentolamine in the treatment of asthmatic pneumonia in the mechanism may be to improve cardiac function, improve pulmonary microcirculation, relieve bronchial spasm and so on. Think that as long as the indications, pay attention to supplement blood volume, phentolamine can be used as a routine auxiliary medication asthmatic pneumonia.